Answers are grounded in this paper and cite their sources.
This study evaluated the stability of volatile organic compounds (VOCs) in exhaled breath samples under different storage conditions (storage at −20 °C vs. room temperature, 25 °C) and analysis times (0 h, 3 h, 6 h, and 12 h). Alveolar exhaled breath samples were collected from 30 volunteers in 500 mL Tedlar® bags, followed by analysis using headspace solid-phase microextraction (HS-SPME) coupled to gas chromatography–mass spectrometry (GC-MS). Seventy-three metabolites were putatively identified, of which 40 met the detection-frequency criterion (present in ≥70% of samples) under both conditions. After excluding two annotations considered physicochemically implausible for headspace analysis (glycine and cholesteryl benzoate), 38 common VOCs were retained. Freezing at −20 °C significantly influenced the variability of 30 of these 38 VOCs (FDR-adjusted p < 0.05). Specifically, freezing reduced the coefficient of variation (CV) of 20 of the 38 metabolites compared to samples kept at room temperature. Six metabolites, including isoprene, methoxyacetic acid, methylcyclohexane and 1-pentene, showed CV < 15% under both conditions. A quantitative drop of more than 90% of the total analytical signal was observed at room temperature by 12 h after sample collection, whereas freezing substantially attenuated, but did not fully eliminate, this signal loss. These findings highlight the influence of pre-analytical conditions on the integrity of volatile profiles, indicating that immediate cold storage is essential in breath biomarker studies. These results provide key criteria for the standardization of breathomics protocols.
No takes yet. Share an insight, caveat, or question.
Villaroel et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: